M. Rizwan Sohail

M. Rizwan Sohail, M.D., FIDSA is a Professor of Medicine in the Department of Infectious Diseases at Baylor College of Medicine's School of Medicine. He concurrently serves as Medical Director of the Faculty Group Practice and holds dual Chief positions at Texas Children's Hospital: Chief of Adult Medical Specialties and Chief of Adult Infectious Diseases in Houston, Texas.

His academic credentials include:

• MD from The Aga Khan University, Karachi, Pakistan
• Fellowship in Infectious Diseases at Mayo Clinic College of Medicine, Rochester, MN
• Residency in Internal Medicine at University of Illinois at Chicago, Chicago, IL

Dr. Sohail's research centers on cardiovascular infections with exceptional depth in device-related infections. His work spans cardiovascular implantable electronic devices (CIEDs), infective endocarditis, ventricular assist devices, and vascular graft infections, while also advancing molecular diagnostics and travel medicine. He addresses critical clinical questions regarding epidemiology, risk stratification, diagnostic approaches, therapeutic management, complications, and outcomes through rigorous clinical investigation.

Analysis of his 200+ publications reveals a strategic evolution toward advanced diagnostics like metagenomic sequencing for culture-negative infections and novel prevention strategies including antimicrobial envelopes. Recent work emphasizes risk prediction models for endocarditis in bacteremia and optimizing management pathways for device infections.

His scientific recognition includes:

• Fellow of the Infectious Diseases Society of America (FIDSA)

Dr. Sohail leads significant research initiatives funded by the American Heart Association, notably developing the PREDICT clinical rule for transesophageal echocardiography use in Staphylococcus aureus bacteremia. He actively shapes national guidelines as a member of the American Heart Association's Council of Clinical Cardiology and Rheumatic Fever/Endocarditis Committee.

As Chief of Adult Infectious Diseases at Texas Children's Hospital, he directs a specialized clinical team managing complex cardiovascular infections, with particular expertise in bridging pediatric and adult care transitions for device-related infections.